I’m currently seeking opportunities to apply my research knowledge and skills to advance your research program. Willing to travel and relocate, I often travel to the Washington,DC/Baltimore area. Contact Information: [email protected] Research Interests Understanding the molecular and genetic mechanisms of human diseases to advance drug discovery, development of therapeutic agents, and improve diagnosis and care for patients. My overall goal is to discover novel classes of biomarkers and therapeutic targets using in-vivo models and translate that knowledge into the clinical realm to advance therapies for patients. Research Background Nuclear Factor Kappa B (NF-kB) is a transcription factor associated with cell survival and cell death outcomes after various myocardial ischemic insults. There was limited knowledge of the mechanism behind the differential effects of NF-kB following ischemic insults that prevented the identification of novel therapeutic targets for myocardial infarction. Action: Designed, executed, and analyzed molecular biology and gene expression experiments to investigate the role of NF-kB. Results: Discovered novel sets of genes that are involved in NF-kB-dependent cardioprotection and cell death. Significance: Identified therapeutic targets more appropriate for clinical development for the treatment of myocardial ischemic heart disease. Major Achievements • Wrote and was awarded a prestigious NIH predoctoral F31 Fellowship ($153,629) • First author and contributing author to manuscripts published in peer-reviewed journals (Journal of Molecular and Cellular Cardiology, Molecular Pharmacology, and Cardiovascular Toxicology) • Presented research findings at laboratory meetings, local seminars, and posters at national research conferences (Experimental Biology 2008 & 2009, International Society for Heart Research North American Section 2008)
